Folgen
Tabea Wiedmer
Tabea Wiedmer
CeMM
Bestätigte E-Mail-Adresse bei cemm.at
Titel
Zitiert von
Zitiert von
Jahr
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
A Di Domenico, T Wiedmer, I Marinoni, A Perren
Endocrine-related cancer 24 (9), R315-R334, 2017
1252017
Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import
E Girardi, G Agrimi, U Goldmann, G Fiume, S Lindinger, V Sedlyarov, ...
Nature communications 11 (1), 6145, 2020
872020
The RESOLUTE consortium: unlocking SLC transporters for drug discovery
G Superti-Furga, D Lackner, T Wiedmer, A Ingles-Prieto, B Barbosa, ...
Nature reviews Drug discovery 19 (7), 429-430, 2020
712020
Autophagy inhibition improves sunitinib efficacy in pancreatic neuroendocrine tumors via a lysosome-dependent mechanism
T Wiedmer, A Blank, S Pantasis, L Normand, R Bill, P Krebs, MP Tschan, ...
Molecular cancer therapeutics 16 (11), 2502-2515, 2017
632017
Three-dimensional primary cell culture: a novel preclinical model for pancreatic neuroendocrine tumors
SL April-Monn, T Wiedmer, M Skowronska, R Maire, M Schiavo Lena, ...
Neuroendocrinology 111 (3), 273-287, 2021
412021
An overview of cell-based assay platforms for the solute carrier family of transporters
V Dvorak, T Wiedmer, A Ingles-Prieto, P Altermatt, H Batoulis, F Bärenz, ...
Frontiers in pharmacology 12, 722889, 2021
382021
Hypo-methylation mediates chromosomal instability in pancreatic NET
I Marinoni, A Wiederkeher, T Wiedmer, S Pantasis, A Di Domenico, ...
Endocr. Relat. Cancer 24 (3), 137-146, 2017
282017
Assessing autophagy in archived tissue or how to capture autophagic flux from a tissue snapshot
M Humbert, M Morán, P de la Cruz-Ojeda, J Muntané, T Wiedmer, ...
Biology 9 (3), 59, 2020
172020
Gain-of-function genetic screens in human cells identify SLC transporters overcoming environmental nutrient restrictions
M Rebsamen, E Girardi, V Sedlyarov, S Scorzoni, K Papakostas, M Vollert, ...
Life Science Alliance 5 (11), 2022
92022
Accelerating SLC transporter research: streamlining knowledge and validated tools
T Wiedmer, A Ingles‐Prieto, U Goldmann, CM Steppan, G Superti‐Furga
Clinical Pharmacology and Therapeutics 112 (3), 439, 2022
72022
Impedance-based phenotypic readout of transporter function: a case for glutamate transporters
HJ Sijben, L Dall’Acqua, R Liu, A Jarret, E Christodoulaki, S Onstein, ...
Frontiers in Pharmacology 13, 872335, 2022
42022
Experimental and computational analysis of newly identified pathogenic mutations in the creatine transporter SLC6A8
E Ferrada, T Wiedmer, WA Wang, F Frommelt, B Steurer, C Klimek, ...
Journal of Molecular Biology 436 (2), 168383, 2024
22024
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
D Sauer, H Li, A Pike, YN Chang, D Prakaash, Z Gelova, J Stanka, ...
12023
Image-based quantification of mitochondrial iron uptake via Mitoferrin-2
M Polesel, MHE Wildschut, C Doucerain, M Kuhn, A Flace, AL Steck, ...
Mitochondrion, 101889, 2024
2024
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Front. Pharmacol. 12: 722889. doi: 10.3389/fphar. 2021.722889
V Dvorak, T Wiedmer, A Ingles-Prieto, P Altermatt, H Batoulis, F Bärenz, ...
Frontiers in Pharmacology| www. frontiersin. org 12, 2021
2021
Epigenetic changes in DAXX and/or ATRX negative pancreatic neuro-endocrine tumours
A Di Domenico, C Pipinikas, C Simillion, T Wiedmer, R Maire, C Thirlwell, ...
VIRCHOWS ARCHIV 473, S2-S2, 2018
2018
Epigenetic Changes in DAXX and/or ATRX Negative Pancreatic Neuro-Endocrine Tumors
A Di Domenico, C Pipinikas, C Simillion, T Wiedmer, R Maire, C Thirlwell, ...
NEUROENDOCRINOLOGY 106, 28-28, 2018
2018
Lysosomal membrane permeabilization as potential mediator of resistance in pancreatic neuroendocrine tumors
T Wiedmer, RM Frank, MP Tschan, A Perren, I Marinoni
Cancer Research 77 (13_Supplement), 3159-3159, 2017
2017
Autophagy Inhibition Improves Current Pancreatic Neuroendocrine Tumor Therapy Via a Lysosome-dependent Mechanism
T Wiedmer
Medizinische Fakultät der Universität Bern, 2017
2017
3D Primary Cell Culture: A New Promising Preclinical Model for Pancreatic Neuro-Endocrine Tumors (pNETs)
I Marinoni, C Mooser, T Wiedmer, A Di Domenico, S Pantasis, A Blank, ...
NEUROENDOCRINOLOGY 105, 31-31, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20